Insulin-like growth factor binding protein-1 (IGFBP-1) during normal pregnancy

Gynecological Endocrinology

Volumn 29, Issue 2, 2013, Pages 129-132

  Larsson, Anders ^a   Palm, Maria ^b   Basu, Samar ^b,c   Axelsson, Ove ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Human; IGFBP 1; Pregnancy

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ARTICLE; CALCULATION; FEMALE; HUMAN; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; LONGITUDINAL STUDIES; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY TRIMESTERS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SWEDEN;

EID: 84871411170     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.730574     Document Type: Article

References (31)

1. Pekonen F, Suikkari AM, Minen T, Rutanen EM. Different insulinlike growth factor binding species in human placenta and decidua. J Clin Endocrinol Metab 1988;67:1250-1257. (Pubitemid 19012961)
2. Julkunen M, Koistinen R, Aalto-Set K, Sepp M, Jne OA, Kontula K. Primary structure of human insulin-like growth factorbinding protein/placental protein 12 and tissue-specific expression of its mRNA. FEBS Lett 1988;236:295-302.
3. Domen HM, Hwa V, Argente J, Wit JM, Wit JM, Camacho-Hner C, Jasper HG, et al.; International ALS Collaborative Group. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences. Horm Res 2009;72:129-141.
4. Clemmons DR. IGF binding proteins and their functions. Mol Reprod Dev 1993;35:368-74; discussion 374.
5. Fowler DJ, Nicolaides KH, Miell JP. Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract. Hum Reprod Update 2000;6:495-504.
6. Froment P, Seurin D, Hembert S, Levine JE, Pisselet C, Monniaux D, Binoux M, Monget P. Reproductive abnormalities in human IGF binding protein-1 transgenic female mice. Endocrinology 2002;143:1801-1808. (Pubitemid 34415895)
7. Cataldo NA, Giudice LC. Insulin-like growth factor binding protein profiles in human ovarian follicular fluid correlate with follicular functional status. J Clin Endocrinol Metab 1992;74:821-829.
8. Irwin JC, Suen LF, Martina NA, Mark SP, Giudice LC. Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum Reprod 1999;14 Suppl 2:90-96. (Pubitemid 30040667)
9. Irwin JC, Suen LF, Faessen GH, Popovici RM, Giudice LC. Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGF-binding protein-1 suggests paracrine interactions at the decidua:trophoblast interface during human implantation. J Clin Endocrinol Metab 2001;86:2060-2064. (Pubitemid 32472920)
10. Elson J, Tailor A, Salim R, Hillaby K, Dew T, Jurkovic D. Expectant management of miscarriage-prediction of outcome using ultrasound and novel biochemical markers. Hum Reprod 2005;20:2330-2333. (Pubitemid 41418527)
11. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994;101:669-674. (Pubitemid 24251519)
12. Rajkumar K, Barron D, Lewitt MS, Murphy LJ. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 1995;136:4029-4034.
13. Doublier S, Duyckaerts C, Seurin D, Binoux M. Impaired brain development and hydrocephalus in a line of transgenic mice with liver-specific expression of human insulin-like growth factor binding protein-1. Growth Horm IGF Res 2000;10:267-274.
14. Howell RJ, Economides D, Teisner B, Farkas AG, Chard T. Placental proteins 12 and 14 in pre-eclampsia. Acta Obstet Gynecol Scand 1989;68:237-240. (Pubitemid 20071751)
15. Tzschoppe AA, Struwe E, D?r HG, Goecke TW, Beckmann MW, Schild RL, D?sch J. Differences in gene expression dependent on sampling site in placental tissue of fetuses with intrauterine growth restriction. Placenta 2010;31:178-185.
16. Okamoto A, Endo H, Kalionis B, Shinya M, Saito M, Nikaido T, Tanaka T. IGFBP1 and Follistatin-like 3 genes are significantly up-regulated in expression profiles of the IUGR placenta. Placenta 2006;27:317-321. (Pubitemid 41763473)
17. Street ME, Seghini P, Fieni S, Ziveri MA, Volta C, Martorana D, Viani I, et al. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur J Endocrinol 2006;155:567-574. (Pubitemid 44608430)
18. Davidson S, Hod M, Merlob P, Shtaif B. Leptin, insulin, insulin-like growth factors and their binding proteins in cord serum: insight into fetal growth and discordancy. Clin Endocrinol (Oxf) 2006;65:586-592. (Pubitemid 44583817)
19. Koutsaki M, Sifakis S, Zaravinos A, Koutroulakis D, Koukoura O, Spandidos DA. Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction. Growth Horm IGF Res 2011;21:31-36.
20. Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH. Maternal serum insulin-like growth factor-binding protein-1 (IGFBP-1) at 11-13 weeks in pre-eclampsia. Prenat Diagn 2011;31:196-201.
21. Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH. Maternal serum insulin-like growth factor (IGF-I) and binding proteins IGFBP-1 and IGFBP-3 at 11-13 weeks' gestation in pregnancies delivering small for gestational age neonates. Eur J Obstet Gynecol Reprod Biol 2012;161:30-33.
22. Solberg HE. The IFCC recommendation on estimation of reference intervals. The RefVal program. Clin Chem Lab Med 2004;42:710-714. (Pubitemid 39137218)
23. Solberg HE. RefVal: a program implementing the recommendations of the International Federation of Clinical Chemistry on the statistical treatment of reference values. Comput Methods Programs Biomed 1995;48:247-256. (Pubitemid 26020880)
24. Olausson H, Lof M, Brismar K, Lewitt M, Forsum E, Sohlstrom A. Longitudinal study of the maternal insulin-like growth factor system before, during and after pregnancy in relation to fetal and infant weight. Horm Res 2008;69:99-106.
25. Clapp JF 3rd, Schmidt S, Paranjape A, Lopez B. Maternal insulin-like growth factor-I levels (IGF-I) reflect placental mass and neonatal fat mass. Am J Obstet Gynecol 2004;190:730-736. (Pubitemid 38406785)
26. Skjaerbaek C, Frystyk J, Orskov H, Flyvbjerg A. Free IGF-I, IGFBP-1, and the binary complex of IGFBP-1 and IGF-I are increased during human pregnancy. Horm Res 2004;62:215-220. (Pubitemid 39551734)
27. Svold BO, Eskild A, Jenum PA, Vatten LJ. Maternal concentrations of insulin-like growth factor I and insulin-like growth factor binding protein 1 during pregnancy and birth weight of offspring. Am J Epidemiol 2011;174:129-135.
28. Akram SK, Carlsson-Skwirut C, Bhutta ZA, Ser O. Placental IGF-I, IGFBP-1, zinc, and iron, and maternal and infant anthropometry at birth. Acta Paediatr 2011;100:1504-1509.
29. Giudice LC, Martina NA, Crystal RA, Tazuke S, Druzin M. Insulinlike growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol 1997;176:751-7; discussion 757.
30. Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, Hintz RL, Rosenfeld RG. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995;80:1548-1555.
31. Cooper S, Lange I, Wood S, Tang S, Miller L, Ross S. Diagnostic accuracy of rapid phIGFBP-I assay for predicting preterm labor in symptomatic patients. J Perinatol 2012;32:460-465.